The IPKat

OCTOBER 2, 2023

In fact, with regards to disclosure requirements of a technical effect, the case law on this topic may primarily be derived from the software field, where the question is more whether any technical effect of the invention is derivable from the application as filed. EPO Guidelines for Examination, H-V, 2.2 ).

Invention 70

Invention Art Publishing Patent 70

IPilogue

DECEMBER 3, 2021

As part of the course requirements, students were asked to write a blog on a topic of their choice. In a case from this year, Hoffman-La Roche v Sandoz , the common law doctrine became even more convoluted. In Canada, methods of medical treatment are unpatentable subject matter.

Intellectual Property Law 106

Intellectual Property Law Patent Infringement Intellectual Property Law 106

The IPKat

DECEMBER 22, 2023

G2/21 and the mysteries of plausibility The topic that this Kat has spent the most electronic ink on this year is undoubtedly G 2/21. After a flurry of decisions at the start of the year , the Boards of Appeal have gone rather silent on the topic of ViCo oral proceedings. This is one to watch for 2024.

Invention 110

Invention Inventor Patent Law 110

IPilogue

JANUARY 14, 2022

v Sandoz Canada Inc. Our hard-working students and community members published more than twice as many articles than in 2020 and the most articles in a calendar year since 2011. Similar to solicitor-client privilege, patent agent privilege was introduced by section 16.1 of the Patent Act on June 24, 2016.

IP 106

IP Copyright Infringement Inventor Intellectual Property 106

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Ziextenzo ® (Sandoz). Hyrimoz ® (Sandoz). Erelzi ® (Sandoz). Zarxio ® (Sandoz). Sandoz / EirGenix). Amgen is also the most common BPCIA defendant (with 8 cases), while Celltrion (defendant in 7 cases) and Sandoz (defendant in 6 cases) are not far behind. 57% off WAC of Remicade ®. Abrilada ™ (Pfizer).

Litigation 52

Litigation Settlement Patent Marketing 52